The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Pear Therapeutics, Inc. and its affiliate on April 12, 2023. The affiliates include Pear Therapeutics (US) Inc. The cases would be jointly administered for administrative and procedural purposes. Pear Therapeutics, Inc. has been designated as the lead debtor.